There is a significant development on the horizon
Health advisers begin meeting Thursday to review more than a half-dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective
56 The United States is the third-largest pork producer, but it does not produce porcine mucosa at meaningful scale for pharmaceutical use
April 30, 2026 regulatory update: On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list for outsourcing facilities, finding no clinical need for large-scale compounding of those substances
It helps your provider set realistic expectations and choose the right peptide, dose, and timing for your life as it actually is